Birth Factors Mostly Explain England's Child Mortality Rate

This article originally appeared here.
Share this content:
Birth Factors Mostly Explain England's Child Mortality Rate
Birth Factors Mostly Explain England's Child Mortality Rate

WEDNESDAY, May 9, 2018 (HealthDay News) -- Birth characteristics largely explain the higher child mortality in England versus Sweden, according to a study published online May 3 in The Lancet.

Ania Zylbersztejn, Ph.D., from the Farr Institute of Health Informatics Research in London, and colleagues used national hospital and administrative data to develop nationally representative cohorts of singleton livebirths in England (3.9 million) and Sweden (1.0 million) between Jan. 1, 2003, and Dec. 31, 2012, with longitudinal follow-up data from hospital admissions and mortality records.

The researchers found that there were 11,392 deaths in England and 1,927 deaths in the Swedish cohort. For England, the unadjusted hazard ratios were 1.66 for 2 to 27 days, 1.59 for 28 to 364 days, and 1.27 for 1 to 4 years, versus the Swedish cohort. Approximately three-quarters of the excess risk of death in England at 2 to 27 days (77 percent) was explained by birth characteristics (e.g., gestational age, birthweight, and congenital anomalies), and an additional 3 percent by socioeconomic factors (e.g., maternal age and socioeconomic status). Similarly, 68 percent of the excess risk of death in England at 28 to 364 days was explained by birth characteristics, and another 11 percent by socioeconomic factors. For deaths between 1 to 4 years, there were no significant differences in the adjusted hazard ratios between the countries.

"Policies to reduce child mortality in England could have most impact by reducing adverse birth characteristics through improving the health of women before and during pregnancy and reducing socioeconomic disadvantage," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »